4-amino-N-(pyridin-2-yl)benzene-1-sulfonamide, 98.0%, 5g

2-Methyl-3-(methylsulfonyl)benzoic acid, 95.0%, 100mg

1-(3-ethyl-5-isoxazolyl)-N-methylmethanamine, 95.0%, 1g

methyl 5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

Ethyl 2-(3-bromophenyl)sulfanylacetate, 25g

ethyl 6-Bromo-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate, 96%, 100mg

Ethyl 1-isopropyl-1H-imidazole-4-carboxylate, 96%, 100mg

2,3:4,6-bis-O-(1-methylethylidene)-α-L-xylo-2-Hexulofuranosonic acid hydrate (1:1), 97%, 100g

N1-(4-Fluorobenzyl)-3-nitro-1,4-phenylenediamine>97.0%(HPLC)(T)5g

2-(Diphenylphosphino)ethyltriethoxysilane, 97%, 250mg

Mevastatin>98.0%(HPLC)100mg

5-Bromo-N-cyclopropyl-2-thiophenecarboxamide, 95.0%, 5g

N-Dodecylacrylamide>97.0%(GC)25g